Maravai LifeSciences Holdings, Inc. Investing Cash Flow
Maravai LifeSciences Holdings, Inc. (MRVI) reported Investing Cash Flow of -$4.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$370.00K.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$4.44M.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$2.11M.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$2.93M.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$31.41M.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$24.32M.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$122.31M.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$267.61M, a 353.29% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$370.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$4.81M 10-Q · filed 2026-08-07 | -$6.92M derived: sum of 3 quarters · filed 2026-08-07 | -$9.85M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | -$4.44M 10-Q · filed 2026-05-08 | -$6.55M derived: sum of 2 quarters · filed 2026-05-08 | -$9.48M derived: sum of 3 quarters · filed 2026-05-08 | -$12.71M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | -$2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.04M derived: sum of 2 quarters · filed 2026-02-26 | -$8.28M derived: sum of 3 quarters · filed 2026-08-07 | -$31.41M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$6.16M derived: sum of 2 quarters · filed 2026-08-07 | -$29.29M 10-Q · filed 2025-11-07 | -$34.22M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | -$3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$26.36M 10-Q · filed 2026-08-07 | -$31.30M derived: sum of 3 quarters · filed 2026-08-07 | -$40.26M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | -$23.13M 10-Q · filed 2026-05-08 | -$28.06M derived: sum of 2 quarters · filed 2026-05-08 | -$37.02M derived: sum of 3 quarters · filed 2026-05-08 | -$43.20M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$4.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$13.89M derived: sum of 2 quarters · filed 2026-02-26 | -$20.07M derived: sum of 3 quarters · filed 2026-02-26 | -$24.32M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$8.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$15.14M derived: sum of 2 quarters · filed 2025-11-07 | -$19.39M 10-Q · filed 2025-11-07 | -$32.29M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | -$6.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$10.43M 10-Q · filed 2025-08-11 | -$23.33M derived: sum of 3 quarters · filed 2026-02-26 | -$38.85M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$4.24M 10-Q · filed 2025-05-12 | -$17.15M derived: sum of 2 quarters · filed 2026-02-26 | -$32.67M derived: sum of 3 quarters · filed 2026-02-26 | -$56.82M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$28.42M derived: sum of 2 quarters · filed 2026-02-26 | -$52.58M derived: sum of 3 quarters · filed 2026-02-26 | -$122.31M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$15.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$39.68M derived: sum of 2 quarters · filed 2024-11-12 | -$109.41M 10-Q · filed 2024-11-12 | -$127.93M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-06-30 | -$24.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$93.89M 10-Q · filed 2024-08-08 | -$112.41M derived: sum of 3 quarters · filed 2025-03-18 | -$118.25M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-03-31 | -$69.73M 10-Q · filed 2024-05-09 | -$88.25M derived: sum of 2 quarters · filed 2025-03-18 | -$94.10M derived: sum of 3 quarters · filed 2025-03-18 | -$95.76M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2022-12-31 | -$18.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$24.37M derived: sum of 2 quarters · filed 2025-03-18 | -$26.03M derived: sum of 3 quarters · filed 2025-03-18 | -$267.61M 10-K · filed 2025-03-18 | |||
| 2022-09-30 | -$5.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$7.51M derived: sum of 2 quarters · filed 2023-11-08 | -$249.09M 10-Q · filed 2023-11-08 | -$254.75M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$243.25M 10-Q · filed 2023-08-08 | -$248.90M derived: sum of 3 quarters · filed 2024-02-29 | -$130.27M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | -$241.58M 10-Q · filed 2023-05-09 | -$247.24M derived: sum of 2 quarters · filed 2024-02-29 | -$128.61M derived: sum of 3 quarters · filed 2024-02-29 | -$133.15M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | -$5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $112.97M derived: sum of 2 quarters · filed 2024-02-29 | $108.44M derived: sum of 3 quarters · filed 2024-02-29 | $105.66M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $118.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $114.09M derived: sum of 2 quarters · filed 2022-11-04 | $111.31M 10-Q · filed 2022-11-04 | $111.32M 10-Q · filed 2021-11-15 | $102.46M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | -$4.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$7.32M 10-Q · filed 2022-08-05 | -$7.23M 10-Q · filed 2021-08-11 | -$16.17M derived: sum of 3 quarters · filed 2023-02-28 | -$26.26M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | -$2.78M 10-Q · filed 2022-05-06 | -$3.03M 10-Q · filed 2021-05-12 | -$11.63M derived: sum of 2 quarters · filed 2023-02-28 | -$21.72M derived: sum of 3 quarters · filed 2023-02-28 | -$24.78M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | -$8.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$18.94M derived: sum of 2 quarters · filed 2023-02-28 | -$22.00M derived: sum of 3 quarters · filed 2023-02-28 | $6.07M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | -$10.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$13.15M derived: sum of 2 quarters · filed 2021-11-15 | $14.92M 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | -$3.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $25.01M 10-Q · filed 2021-08-11 | |||||
| 2020-03-31 | $28.07M 10-Q · filed 2021-05-12 | ||||||
| 2019-12-31 | -$17.15M 10-K · filed 2022-03-01 |